LH
Leslie Hudson
Former CEO

Leslie Hudson insider trades: Avi Biopharma (AVII) stock sales

Former CEO, Avi Biopharma Last trade Jul 30, 2010 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2008
4
Companies
last trade 2010

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Leslie reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 30, 2010AVII↓ Sell$354K
Jul 28, 2010AVII↓ Sell$334K
Jul 26, 2010AVII↓ Sell$246K
Jul 23, 2010AVII↓ Sell$370K
Jul 22, 2010AVII↓ Sell$478K
Jul 16, 2010AVII↓ Sell$188K
Jul 9, 2010AVII↓ Sell$316K
Jul 7, 2010AVII↓ Sell$292K
Jul 6, 2010AVII↓ Sell$32K
Jul 2, 2010AVII↓ Sell$297K
Apr 3, 2008NABI↓ Sell$98K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Leslie Hudson's insider trades

Leslie Hudson is Former CEO at Avi Biopharma (AVII). Since Apr 3, 2008, Leslie has reported no open-market purchases and 11 sales worth $3.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (11 filings), option exercises (10 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVII insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.